期刊文献+

恶性肿瘤高凝状态患者的临床特征 被引量:24

Clinical characteristics of malignant tumor with hypercoagulability
下载PDF
导出
摘要 目的:探讨恶性肿瘤高凝状态的临床特点。方法:选取2014年3月至2016年7月就诊于新乡医学院第三附属医院肿瘤科的140例恶性肿瘤患者,根据恶性肿瘤高凝状态的诊断标准将其分为高凝状态组和非高凝状态组。对两组患者的临床资料及凝血指标进行比较与分析。结果:140例恶性肿瘤患者中有62例(44.3%)存在高凝状态。高凝状态组患者PLT、PT、FIB及D-D水平明显高于非高凝状态组,差异均有显著统计学意义(P<0.01),APTT水平比较差异无统计学意义(P>0.05)。高凝状态组患者肺转移、淋巴结转移、肿瘤分期比例显著高于非高凝状态组,差异均有统计学意义(P<0.05),两组患者性别、年龄、肝转移及肿瘤部位比较差异均无统计学意义(P>0.05)。结论:恶性肿瘤患者存在高凝状态,根据其临床特征和凝血功能检测有助于及时发现这种状态,并及时干预可使患者获益。 Objective : To investigate the clinical characteristics of malignant tumor with hypercoagulability. Meth- ods:The data 140 cases of malignant tumor patients were selected in the Third Affiliated Hospital of Xinxiang Medical University from March 2014 to July 2016. All patients were divided into hypercoagulability group (62 cases) and non - hypercoagulability group (78 cases) according to whether with hypercoagulability or not. The clinical data and co- agulation index were compared between the two groups. Results: 140 cases of patients with malignant tumor in 62 ca- ses (44.3%) had hypercoagulability. The level of PLT,PT,FIB and D -D in hypercoagnlability group were significantlyhigher than non - hypercoagnlability group (P 〈 0.01 ) , there was no significant difference in the level of APTr be- tween the two groups ( P 〉 0.05 ). The proportion of lung metastasis, lymph node metastasis and tumor stage were sig- nificantly higher in the patients with hypercoagulability group than in the non - hypercoagnlability group ( P 〈 0.05 ), there was no significant difference in gender, age, liver metastasis and tumor position between the 2 groups (P 〉 0.05). Conclusion: Hypercoagulability existed in patients with malignant tumors, we must timely discover this state according to the the clinical characteristics and test of coagulation index, and timely intervention measures to make benefits to these patients.
出处 《现代肿瘤医学》 CAS 2017年第13期2100-2103,共4页 Journal of Modern Oncology
基金 河南省医学科技攻关计划项目(编号:201503138) 河南省高等学校重点科研项目计划(编号:16A320041) 新乡市第一批科技创新发展专项项目(编号:CXGG16016)
关键词 恶性肿瘤 高凝状态 凝血指标 malignant tumor, hypercoagulability, coagulation index
  • 相关文献

参考文献7

二级参考文献74

  • 1王胜,徐笑红,包叶江.恶性肿瘤患者血小板系列参数的临床意义[J].浙江中西医结合杂志,2006,16(2):88-89. 被引量:8
  • 2陈芳,宁琴,孙汉英,苏凯,严伟明,习东,罗小平,刘文励.恶性肿瘤组织中人纤维介素的表达及作用[J].华中科技大学学报(医学版),2006,35(4):444-448. 被引量:8
  • 3中国肿瘤防治办公室 中国抗癌协会合编.中国常见恶性肿瘤诊治规范[M].北京:中国协和医科大学北京医科大学联合出版社,1991.1-13.
  • 4Rocco G, Cicalese M, La Manna C, La Rocca A, Martucci N, Salvi R. Ultrasonographic identification of peripheral pulmonary nodules through uniportal video-assisted thoracic surgery. Ann Thorac Surg 2011;92:1099-101.
  • 5Piolanti M, Coppola F, Papa S, Pilotti V, Mattioli S, Gavelli G. Ultrasonographic localization of occult pulmonary nodules during video-assisted thoracic surgery. Eur Radio12003;13:2358-64.
  • 6Mattioli S, D'Ovidio F, Daddi N, Ferruzzi L, Pilotti V, Ruffato A, et al. Transthoracic endosonography for the intraoperative localization of lung nodules. Ann Thorac Surg 2005;79:443-9.
  • 7Yendamuri S, Demmy TL. Is VAMLA/TEMLA the new standard of preresection staging of non-small cell lung cancer? J Thorac Cardiovasc Surg 2012;144:S14-7.
  • 8Zielifiski M, Hauer L, Hauer J, Pankowski J, Szlubowski A, Nabialek T. Transcervical Extended Mediastinal Lymphadenectomy (TEMLA) for staging of non-small-cell lung cancer (NSCLC). Pneumonol Alergol Pol 2011;79:196-206.
  • 9Zielifiski M, Hauer L, Hauer J, Nabiatek T, Szlubowski A, Pankowski J. Non-small-cell lung cancer restaging with transcervical extended mediastinal lymphadenectomy. EurJ Cardiothorac Surg 2010;37:776-80.
  • 10Hennon M, Sahai RK, Yendamuri S, Tan W, Demmy TL, Nwogu C. Safety of thoracoscopic lobectomy in locally advanced lung cancer. Ann Surg Onco12011;18:3732-6.

共引文献248

同被引文献304

引证文献24

二级引证文献97

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部